NCT04345367: Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
- State
- Completed
- Phase
- Phase 3
- People
- 727 taking part
- Started
- 11 Jun 2020
- Primary completion
- 13 Jul 2021
- Arms
- Abrocitinib 200 mg plus placebo injection
- Results
- Posted on the registry
- 14 Apr 2020: Trial registered
- 11 Jun 2020: Trial started
- 13 Jul 2021: Trial completed
- 8 Jul 2022: Trial results posted